| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.36 | 0.02 |